Physician profile
Kyle D Klute
NPI 1235556804
$3,664.64
in general payments reported to CMS, 2019-2025
15 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $1,091 · 2021: $226 · 2022: $139 · 2023: $346 · 2024: $577 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Food and Beverage | $607.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,045.00 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $931.59 | 2025 | Xdemvy |
| Coopervision INC. | $582.78 | 2021-2024 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $433.33 | 2021-2025 | Dailies Total1, Total30 |
| Shire North American Group INC | $123.52 | 2019 | |
| Lkc Technologies, INC. | $110.93 | 2023-2025 | |
| Sight Sciences, INC. | $107.57 | 2019-2023 | Tearcare System |
| Allergan, INC. | $98.35 | 2022 | |
| Topcon Healthcare, INC. | $57.84 | 2023 | |
| Optos, INC. | $45.00 | 2019 | |
| Carl Zeiss Meditec Ag | $34.40 | 2020 | |
| New World Medical,INC. | $28.56 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $25.59 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $21.27 | 2022 | |
| Glaukos Corporation | $18.91 | 2024 | Idose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Klute listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.